Bailey Crandall, PharmD, BCPS, BCOP

Article

Cardiovascular Effects of Tyrosine Kinase Inhibitors in Patients With Advanced Renal Cell Carcinoma at the VA San Diego Healthcare System (FULL)

Author:: Bailey Crandall, PharmD, BCPS, BCOP

Publish date: May 2, 2020

Patients who have or are at high risk for developing cardiovascular disease and who are taking tyrosine kinase inhibitors for renal cell carcinoma ...